Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enable long-term drug-free virological control in rare individuals. We describe a female who maintained aviremia and a normal CD4+/CD8+ T cell ratio for 10 years after stopping therapy, despite a per-sistent viral reservoir. Cellular immune responses may have contributed to this outcome
BACKGROUND: Virus-specific cellular immune responses mediated by CD4 and CD8 T lymphocytes are thoug...
Virus-specific T-helper cells are considered critical for the control of chronic viral infections. S...
There is conflicting data on long-term CD4 immune recovery after combination antiretroviral therapy ...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
<div><p>Combination antiretroviral therapy (cART) reduces HIV-associated morbidities and mortalities...
Background: Early ART initiation is associated with impact on HIV-1 reservoir establishment and deca...
International audienceCombination antiretroviral therapy (cART) reduces HIV-associated morbidities a...
Abstract Background While initiation of highly active antiretroviral therapy (HAART) during primary ...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
Human immunodeficiency virus type 1 (HIV-1)-infected subjects treated early after infection have pre...
Background Long-term treatment of primary HIV-1 infection (PHI) may allow the immune reconstitution ...
Potent antiretroviral therapy has dramatically improved the prognosis of patients infected with HIV-...
BACKGROUND: Virus-specific cellular immune responses mediated by CD4 and CD8 T lymphocytes are thoug...
Virus-specific T-helper cells are considered critical for the control of chronic viral infections. S...
There is conflicting data on long-term CD4 immune recovery after combination antiretroviral therapy ...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enabl...
<div><p>Combination antiretroviral therapy (cART) reduces HIV-associated morbidities and mortalities...
Background: Early ART initiation is associated with impact on HIV-1 reservoir establishment and deca...
International audienceCombination antiretroviral therapy (cART) reduces HIV-associated morbidities a...
Abstract Background While initiation of highly active antiretroviral therapy (HAART) during primary ...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
Human immunodeficiency virus type 1 (HIV-1)-infected subjects treated early after infection have pre...
Background Long-term treatment of primary HIV-1 infection (PHI) may allow the immune reconstitution ...
Potent antiretroviral therapy has dramatically improved the prognosis of patients infected with HIV-...
BACKGROUND: Virus-specific cellular immune responses mediated by CD4 and CD8 T lymphocytes are thoug...
Virus-specific T-helper cells are considered critical for the control of chronic viral infections. S...
There is conflicting data on long-term CD4 immune recovery after combination antiretroviral therapy ...